Sumitomo Life Insurance CO Abbott Laboratories Transaction History

Sumitomo Life Insurance CO

$5.08 Billion
Q3 2024

A detailed history of Sumitomo Life Insurance CO transactions in Abbott Laboratories stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 13,282 shares of ABT stock, worth $1.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,282

Previous 12,958 2.5%

Holding current value

$1.56 Million

Previous $1.35 Million 12.48%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$100.07 - $118.13 $32,422 - $38,274	324 Added 2.5%	13,282 $1.51 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $167,111 - $186,537	-1,659 Reduced 11.35%	12,958 $1.35 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $63,193 - $69,793	-577 Reduced 3.8%	14,617 $1.66 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $71,159 - $87,105	-789 Reduced 4.94%	15,194 $1.67 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $19,774 - $23,726	-207 Reduced 1.28%	15,983 $1.55 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $138,874 - $154,735	-1,378 Reduced 7.84%	16,190 $1.77 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $12,591 - $14,821	-130 Reduced 0.73%	17,568 $1.78 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $36,312 - $42,600	-382 Reduced 2.11%	17,698 $1.94 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $210,936 - $244,225	-2,180 Reduced 10.76%	18,080 $1.75 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $40,828 - $49,348	400 Added 2.01%	20,260 $2.2 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $1.31 Million - $1.6 Million	-11,509 Reduced 36.69%	19,860 $2.35 Million
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $107,096 - $131,133	-927 Reduced 2.87%	31,369 $4.42 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $159,124 - $176,037	-1,364 Reduced 4.05%	32,296 $3.82 Million
Q2 2021 Jul 20, 2021	SELL	$105.79 - $124.53 $545,453 - $642,076	-5,156 Reduced 13.28%	33,660 $3.9 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $266,875 - $314,419	-2,452 Reduced 5.94%	38,816 $4.65 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $317,310 - $345,777	-3,022 Reduced 6.82%	41,268 $4.52 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $307,910 - $373,934	-3,360 Reduced 7.05%	44,290 $4.82 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $317,459 - $406,308	-4,146 Reduced 8.0%	47,650 $4.36 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $46,800 - $68,435	745 Added 1.46%	51,796 $4.09 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $225,323 - $250,838	2,870 Added 5.96%	51,051 $4.43 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $493,904 - $535,545	-6,035 Reduced 11.13%	48,181 $4.03 Million
Q2 2019 Jul 26, 2019	BUY	$72.88 - $85.0 $159,315 - $185,810	2,186 Added 4.2%	54,216 $4.56 Million
Q1 2019 Apr 17, 2019	SELL	$66.22 - $80.06 $366,196 - $442,731	-5,530 Reduced 9.61%	52,030 $4.16 Million
Q4 2018 Jan 24, 2019	BUY	$65.56 - $74.27 $66,936 - $75,829	1,021 Added 1.81%	57,560 $4.16 Million
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $1.16 Million - $1.4 Million	-19,089 Reduced 25.24%	56,539 $4.15 Million
Q2 2018 Jul 23, 2018	BUY	$57.57 - $63.54 $175,646 - $193,860	3,051 Added 4.2%	75,628 $4.61 Million
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $179,895 - $203,393	-3,197 Reduced 4.22%	72,577 $4.35 Million
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $197,542 - $211,489	-3,680 Reduced 4.63%	75,774 $4.32 Million
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $3.82 Million - $4.26 Million	79,454	79,454 $4.24 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Abbott Laboratories Transaction History